Cargando…

The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer

OBJECTIVE: To investigate the diagnostic value of magnetic resonance imaging (MRI) combined with serum alpha-fetoprotein (AFP), alpha-fetoprotein (AFP-L3), Golgi protein 73 (GP73), and des-γ-carboxyprothrombin (DCP) on early-stage primary liver cancer (PHC). METHODS: A total of 122 patients who were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Zhongjing, Jin, Kai, Jing, Junpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584718/ https://www.ncbi.nlm.nih.gov/pubmed/36277979 http://dx.doi.org/10.1155/2022/8640999

Ejemplares similares

Retracted: The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer
por: Markers, Disease
Publicado: (2023)

A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
por: Pang, Bing-yao, et al.
Publicado: (2022)

Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
por: Wang, Xueying, et al.
Publicado: (2020)

Magnetic Resonance Imaging and Serum AFP-L3 and GP-73 in the Diagnosis of Primary Liver Cancer
por: Yuan, Jun-Jian, et al.
Publicado: (2022)

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013)

Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer
por: Yu, Chuanwen, et al.
Publicado: (2022)

GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021)

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
por: Qi, Famei, et al.
Publicado: (2019)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023)

Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds
por: Song, Ting, et al.
Publicado: (2020)

AFP
Publicado: (2009)

Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
por: Wu, Min, et al.
Publicado: (2018)

Status of AFP
por: Erland, Paula Agnieszka
Publicado: (2019)

The AFP Project
por: Staszewski, R.
Publicado: (2011)

Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases
por: Wang, Ting, et al.
Publicado: (2017)

Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
por: Liu, Ruoyu, et al.
Publicado: (2021)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
por: Nguyen, Hoang Bac, et al.
Publicado: (2022)

DCS and TDAQ for AFP
por: Banas, Elzbieta, et al.
Publicado: (2017)

AFP Project in ATLAS
por: Tasevsky, M
Publicado: (2017)

First AFP results
por: Staszewski, Rafal
Publicado: (2017)

Overview of AFP performance
por: Liu, Jesse Kar Kee
Publicado: (2021)

The ATLAS AFP Spectrometer
por: Newman, Paul Richard
Publicado: (2021)

Overview of AFP Detector
por: Auriol, Adrien
Publicado: (2023)

The Value of Color Doppler Ultrasound and CT Combined with Serum AFP Examination in the Diagnosis of Hepatocellular Carcinoma
por: Jia, Peiwan, et al.
Publicado: (2022)

Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP
por: Wang, Ya-Kun, et al.
Publicado: (2018)

Status of the AFP Project in ATLAS
por: Tasevsky, Marek
Publicado: (2017)

ATLAS AFP: Status and Prospects
por: Newman, Paul
Publicado: (2018)

The AFP detector control system
por: Oleiro Seabra, Luis Filipe, et al.
Publicado: (2017)

The AFP and CT-PPS projects
por: Royon, C., et al.
Publicado: (2015)

Physics goals and status of AFP
por: Trzebinski, Maciej
Publicado: (2015)

Backgrounds in AFP Detector Estimation
por: Huang, Yicong
Publicado: (2016)

The tracking system of the AFP detector.
por: Dyndal, M
Publicado: (2014)

The AFP Detector Control System
por: Oleiro Seabra, Luis Filipe
Publicado: (2017)

Analysis with AFP and ATLAS Detectors
por: Erland, Paula Agnieszka
Publicado: (2022)

Retracted: The Value of Color Doppler Ultrasound and CT Combined with Serum AFP Examination in the Diagnosis of Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma
por: Mao, Liping, et al.
Publicado: (2017)

AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis
por: Zhou, Jian-Ming, et al.
Publicado: (2021)

Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis
por: Liu, Siyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kgk098k321ekj6f0ochn8sosv7